Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PROCEPT BioRobotics (PRCT) EPS (Basic) (2020 - 2025)

PROCEPT BioRobotics (PRCT) has disclosed EPS (Basic) for 6 consecutive years, with -$0.53 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 55.88% to -$0.53 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.72, a 1.71% increase, with the full-year FY2025 number at -$1.72, up 1.71% from a year prior.
  • EPS (Basic) was -$0.53 for Q4 2025 at PROCEPT BioRobotics, down from -$0.39 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.01 in Q4 2021 to a low of -$2.65 in Q1 2021.
  • A 5-year average of -$0.61 and a median of -$0.51 in 2022 define the central range for EPS (Basic).
  • Peak YoY movement for EPS (Basic): surged 164.22% in 2021, then plummeted 131.34% in 2022.
  • PROCEPT BioRobotics' EPS (Basic) stood at $2.01 in 2021, then tumbled by 131.34% to -$0.63 in 2022, then rose by 14.29% to -$0.54 in 2023, then soared by 37.04% to -$0.34 in 2024, then crashed by 55.88% to -$0.53 in 2025.
  • Per Business Quant, the three most recent readings for PRCT's EPS (Basic) are -$0.53 (Q4 2025), -$0.39 (Q3 2025), and -$0.35 (Q2 2025).